Literature DB >> 2710360

Kearns-Sayre syndrome and complex II deficiency.

M H Rivner1, M Shamsnia, T R Swift, J Trefz, R A Roesel, A L Carter, W Yanamura, F A Hommes.   

Abstract

A 25-year-old woman with Kearns-Sayre syndrome (KSS) had complete external ophthalmoplegia, short stature, ataxia, cardiac conduction defects, and pigmentary retinopathy. Muscle biopsy revealed ragged-red fibers. Electron microscopy showed increased numbers of mitochondria with disordered structure and paracrystalline inclusions. Enzymatic analysis revealed a deficiency of complex II of the mitochondrial respiratory chain, and, more specifically, a deficiency of succinic dehydrogenase, although both subunits of this enzyme proved to be present by immunologic analysis. Therapy with vitamin cofactors did not result in short-term improvement. This appears to be the first report of complex II deficiency in a patient with KSS.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2710360     DOI: 10.1212/wnl.39.5.693

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  12 in total

Review 1.  Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy.

Authors:  M Votruba; A T Moore; S S Bhattacharya
Journal:  J Med Genet       Date:  1998-10       Impact factor: 6.318

2.  Mitochondrial myopathy with succinate dehydrogenase and aconitase deficiency. Abnormalities of several iron-sulfur proteins.

Authors:  R E Hall; K G Henriksson; S F Lewis; R G Haller; N G Kennaway
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

3.  A case of Kearns-Sayre syndrome with metaphyseal dysplasia.

Authors:  B Wilson; I Claësson; C Forsell; M Tulinius; B Hagberg
Journal:  Pediatr Radiol       Date:  1993

4.  The effects of vigabatrin on electrophysiology and visual fields in epileptics: a controlled study with a discussion of possible mechanisms.

Authors:  I F Comaish; C Gorman; G M Brimlow; C Barber; G M Orr; N R Galloway
Journal:  Doc Ophthalmol       Date:  2002-03       Impact factor: 2.379

5.  Mutation of the fumarase gene in two siblings with progressive encephalopathy and fumarase deficiency.

Authors:  T Bourgeron; D Chretien; J Poggi-Bach; S Doonan; D Rabier; P Letouzé; A Munnich; A Rötig; P Landrieu; P Rustin
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

Review 6.  Muscle mitochondrial DNA in encephalomyopathy and ragged red fibres: a Southern blot analysis and literature review.

Authors:  C Geny; V Cormier; C Meyrignac; P Cesaro; J D Degos; R Gherardi; A Rötig
Journal:  J Neurol       Date:  1991-06       Impact factor: 4.849

7.  Deficiency of skeletal muscle succinate dehydrogenase and aconitase. Pathophysiology of exercise in a novel human muscle oxidative defect.

Authors:  R G Haller; K G Henriksson; L Jorfeldt; E Hultman; R Wibom; K Sahlin; N H Areskog; M Gunder; K Ayyad; C G Blomqvist
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

8.  A metabolic model of the mitochondrion and its use in modelling diseases of the tricarboxylic acid cycle.

Authors:  Anthony C Smith; Alan J Robinson
Journal:  BMC Syst Biol       Date:  2011-06-29

Review 9.  Human Metabolic Enzymes Deficiency: A Genetic Mutation Based Approach.

Authors:  Swati Chaturvedi; Ashok K Singh; Amit K Keshari; Siddhartha Maity; Srimanta Sarkar; Sudipta Saha
Journal:  Scientifica (Cairo)       Date:  2016-03-09

Review 10.  Combined defects in oxidative phosphorylation and fatty acid β-oxidation in mitochondrial disease.

Authors:  Abena Nsiah-Sefaa; Matthew McKenzie
Journal:  Biosci Rep       Date:  2016-02-02       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.